Integrated Quality of Care System (SIC)

icono DM2

Diabetes Mellitus

Comparative between states and jurisdictions
  < Back
Comparison between states is shown by default. For more details, select your state and Jurisdiction.
State: Jurisdiction:  
Type of patient:

Characteristics of people living with diabetes mellitus (DM2)

N = 1,062,722 (Date of update – Jun 23 2019 11:39PM)

Distribution by age group and gender

Of all people living with DM2:
759,349 (71.5%) are women
303,373 (28.5%) are men
Distribution by comorbidity

Of all people living with DM2:
306,473 (28.8%) only have DM2 72,581 (6.8%) have dyslipidemia
208,905 (19.7%) have hypertension 383,857 (36.1%) have MS
90,907 (8.6%) have obesity  

Quality of care granted

% with at least one visit to the doctor's office
[within the last 2 months]
% with glucose measurement
[in the last visit]
% with feet exam
[in the last visit]

Control of disease

% patients with at least one measurement of A1c

of patients with DM2 have at least one measurement of A1c in the SIC
% with A1c measurement within the last 12 months

Of all patients by A1c result:
44.2% with A1c < 7
55.8% with A1c >= 7, allocated as follows:
      30.8% with A1c between 7 and 9
       25.0% with A1c > 9

Treatment prescribed to patients with DM2

Since more than one medication may be prescribed to individual patients, the sum of medications may be greater than 100.
Of all people with DM2 with prescription in their last visit ( 968,256):
293,532 (30.3%) are prescribed insulin
454,398 (46.9%) are prescribed glibenclamide
844,371 (87.2%) are prescribed metformin